Skip to main content
TipRanks
Go Ultimate75% OFF

Indraprastha Medical Corporation Limited (INDRAMEDCO) Stock Price & Analysis

6 Followers

INDRAMEDCO Stock Chart & Stats

₹338.55₹6.95(2.10%)
At close: 3:30 PM GMT+5:30
₹300₹325₹350₹375Aug 17Aug 31Sep 15Sep 28Oct 12Oct 26Nov 9
Day’s Range
INR 332.00 - INR 339.35
52-Week Range
INR 293.50 - INR 555.75
Previous Close
INR 331.60
Volume
350.29K
Average Volume (3M)
9,281
Market Cap
INR 30.40B
Enterprise Value
INR 28.89B
Total Cash (Recent Filing)
INR 2.63B
Total Debt (Recent Filing)
INR 0
Price to Earnings (P/E)
16.2
Beta
1.56
Next Earnings
Feb 09, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
1.21%

Bulls Say, Bears Say

Bulls Say

Multi-year Revenue Growth

Revenue increased from 6.13B in 2021 to 14.83B in 2026, with positive growth in each of the last five years. This sustained expansion indicates broader hospital activity and supports a larger operating base, even as the latest growth rate moderated.

Profitability Recovery

The substantial improvement in net and EBIT margins shows that the company has converted revenue growth into materially stronger operating economics. A healthier margin structure can support reinvestment, resilience, and more dependable earnings generation over the next several quarters.

Low Financial Leverage

Very low leverage and a much larger equity base provide financial flexibility as the business scales. Limited reliance on debt reduces balance-sheet strain and leaves greater capacity to absorb operating variability or fund future needs without excessive financing pressure.

Bears Say

Slowing Latest Growth

Although the long-term growth record remains positive, the slowdown to roughly 5.5% in 2026 indicates that recent expansion has lost momentum. If this moderation persists, it could limit operating leverage and make future profit growth more dependent on margin improvement.

Gross Margin Volatility

The pronounced variation in gross margin suggests that service mix or cost economics have not been consistently stable. Even with stronger EBIT margins, recurring gross-margin swings can make profitability less predictable and complicate long-term planning and reinvestment decisions.

Uneven Cash-flow Pattern

Cash generation is strong overall, but the year-to-year pattern has been uneven, with a 2025 setback before the 2026 rebound. Such volatility may reflect working-capital or spending timing effects and can reduce confidence in the consistency of near-term internally generated funding.

INDRAMEDCO FAQ

What was Indraprastha Medical Corporation Limited’s price range in the past 12 months?
Indraprastha Medical Corporation Limited lowest stock price was ₹293.50 and its highest was ₹555.75 in the past 12 months.
What is Indraprastha Medical Corporation Limited’s market cap?
Indraprastha Medical Corporation Limited’s market cap is ₹30.40B.
When is Indraprastha Medical Corporation Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Indraprastha Medical Corporation Limited’s earnings last quarter?
Indraprastha Medical Corporation Limited released its earnings results on Oct 29, 2026. The company reported ₹5.845 earnings per share for the quarter.
Is Indraprastha Medical Corporation Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Indraprastha Medical Corporation Limited pay dividends?
Indraprastha Medical Corporation Limited pays an annual dividend of ₹4 which represents an annual dividend yield of 1.21%. See more information on Indraprastha Medical Corporation Limited dividends here
What is Indraprastha Medical Corporation Limited’s EPS estimate?
Indraprastha Medical Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Indraprastha Medical Corporation Limited have?
Indraprastha Medical Corporation Limited has 91,673,000 shares outstanding.
What happened to Indraprastha Medical Corporation Limited’s price movement after its last earnings report?
Indraprastha Medical Corporation Limited reported an EPS of ₹5.845 in its last earnings report. Following the earnings report the stock price went up 1.018%.
Which hedge fund is a major shareholder of Indraprastha Medical Corporation Limited?
Currently, no hedge funds are holding shares in IN:INDRAMEDCO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology